Molsidomine
WikiDoc Resources for Molsidomine |
Articles |
---|
Most recent articles on Molsidomine Most cited articles on Molsidomine |
Media |
Powerpoint slides on Molsidomine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Molsidomine at Clinical Trials.gov Clinical Trials on Molsidomine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Molsidomine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Molsidomine Discussion groups on Molsidomine Patient Handouts on Molsidomine Directions to Hospitals Treating Molsidomine Risk calculators and risk factors for Molsidomine
|
Healthcare Provider Resources |
Causes & Risk Factors for Molsidomine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Molsidomine is an orally active, long acting vasodilating drug. Molsidomine is metabolized in the liver to the active metabolite SIN-1. SIN-1 is an unstable compound that releases nitric oxide upon decay as the actual vasodilating compound.
Chemistry
Molsidomine as well as SIN-1 are sydnone imines, a class of mesoionic heterocyclic aromatic chemical compounds.
See also
- Nitric oxide
- Nitric oxide releaser
- Vasodilator